Otsuka Holdings Co., Ltd. OTSKY
Set alert
37.23 USD -0.48 -1.26%
As of Nov 2, 3:52 PM ET
37.17 Day range 37.31
26.11 52-week range 40.92
- YTD
- +31.42%
- 1 year
- +37.03%
- Open
- 37.17
- Prev close
- 37.71
- Mkt cap
- 39.01B
- Vol
- 2.28K
- Avg vol
- 44.80K
- EPS
- 2.28
- P/E
- 16.33
More statistics
- Low
- 37.17
- High
- 37.31
- Earnings
- Oct 30, 2026
3M chart
Events in this range
- Oct 30, 2026Earnings: —; estimate 0.56; surprise —%
Signals (18)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 2026 | 14 hours ago |
| SMA: Bearish | Nov 2, 2026 | 14 hours ago |
| MACD: Sell Signal | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 13, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 21, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 20, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 19, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
Next earnings
Oct 30, 2026
Expected Oct 30, 2026. Consensus EPS estimate 0.56.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 30, 2026 | Sep 30, 2026 | 0.56 | — | — | — |
| Jul 31, 2026 | Jun 30, 2026 | 0.506 | 0.70 | +0.19 | +38.34% |
| Apr 29, 2026 | Mar 31, 2026 | 0.4306 | 0.583 | +0.15 | +35.39% |
| Feb 12, 2026 | Dec 31, 2025 | 0.2377 | 0.4057 | +0.17 | +70.68% |
| Oct 31, 2025 | Sep 30, 2025 | 0.515 | 0.797 | +0.28 | +54.76% |
| Apr 30, 2025 | Mar 30, 2025 | 0.3947 | 0.556 | +0.16 | +40.87% |
News
- Otsuka (OTCMKTS:OTSKY) Shares Gap Down – Here’s Why
- Critical Survey: Inhibikase Therapeutics (NASDAQ:IKT) and Otsuka (OTCMKTS:OTSKY)
- Otsuka, Ionis' experimental ALS drug meets main goal in late-stage study
- Otsuka Announces Transformative Phase 3 FUSION Results for Ulefnersen, Bringing the FUS-ALS Community Closer to a Potential Targeted Treatment
- Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study Prepared Remarks Transcript
- Otsuka Holdings Co., Ltd. (OTSKY) Q2 2026 Earnings Call Prepared Remarks Transcript
- Aristotle Global Equity Advisory Q2 2026 Portfolio Review
- Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America
- AstraZeneca (OTCMKTS:AZNCF) versus Otsuka (OTCMKTS:OTSKY) Financial Review
- Otsuka Holdings Co., Ltd. (OTSKY) M&A Call Prepared Remarks Transcript
Your note
Sign in to keep a note on OTSKY — it syncs with the Stock Master app.